Related Experiment Video
Updated: Dec 10, 2025
09:42
Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation
Published on: November 8, 2013
13.8K
Pulmonary Rehabilitation: Time for an Upgrade
1Department of Rehabilitation, Hospital Clínic de Barcelona, 08036 Barcelona, Spain.
Journal of Clinical Medicine
|August 29, 2020
Summary
Pulmonary rehabilitation improves quality of life for chronic respiratory disease patients but remains underused. The COVID-19 pandemic presents new challenges and opportunities for this vital intervention.
Area of Science:
- Pulmonology and Respiratory Medicine
- Rehabilitation Science
- Public Health
Background:
- Pulmonary rehabilitation (PR) is a proven intervention for chronic respiratory diseases, enhancing functional capacity and quality of life.
- Despite decades of research demonstrating PR benefits, its clinical application remains significantly limited.
- The COVID-19 pandemic has introduced new complexities and highlighted the need for accessible PR.
Discussion:
- Addressing the underutilization of PR requires overcoming systemic barriers and increasing patient access.
- Integrating PR into routine care is crucial for managing chronic respiratory conditions effectively.
- Emerging challenges, including those posed by the COVID-19 pandemic, necessitate innovative approaches to PR delivery.
Key Insights:
- PR significantly improves symptom management and health-related quality of life in patients with chronic respiratory diseases.
- Hundreds of studies confirm the efficacy of PR, yet widespread adoption is lacking.
- The evolving landscape of respiratory care, especially post-COVID-19, demands a re-evaluation of PR strategies.
Outlook:
- Future PR research should focus on optimizing delivery models and addressing health inequities.
- Adapting PR for the post-COVID-19 era is essential for maximizing patient outcomes.
- Increased awareness and advocacy are needed to promote the broader implementation of pulmonary rehabilitation.
Related Concept Videos
01:25Pulmonary Function Tests
603
Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
603
01:16Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
476
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
476
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.9K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.9K
01:28Pneumonia IV: Management
637
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
637
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
151
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
151
01:17Other Pulmonary Disorders
1.4K
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
1.4K